The University of Portsmouth is joining forces with brain tumour charity, Brainstrust and other partners to create a centre of excellence for brain tumour research on the South Coast.
Brain tumours are the most lethal and devastating tumours. They are the most common cause of death in children after accidents and the most common form of cancer in people under 40.
The new centre will focus entirely on dedicated laboratory-based brain tumour research in both adults and children.
Professor of Cellular & Molecular Neuro-oncology, Geoff Pilkington, who is leading the research team at Portsmouth, is chairing an open day at the University today to showcase the current facilities and to introduce major collaborators to the University.
Attendees include cricketer Alan Igglesden, the former Kent and England fast bowler, who was first diagnosed with a brain tumour several years ago. He is currently receiving treatment by Professor Pilkington and has long been a supporter of his work.
He and other brain tumour patients will hear about the current neuro-oncology research projects at Portsmouth and about the latest research in the field such as the development of new drug delivery systems to the brain.
Representatives from neurosurgical centres and charities which are currently funding research at the University will also attend, including leading brain tumour charities such as Ali’s Dream, Brain Tumour UK, and Charlie’s Challenge. Other attendees include senior clinical neuro-science staff from Southampton General Hospital and trustees, patrons and key supporters of Brainstrust.
Professor Pilkington said: “The aim of the collaboration between Brainstrust and Portsmouth University is to fund new specialist staff in neuro-oncology to further our research and to raise funds to buy equipment and provide essential running costs.”
Dr Helen Bulbeck is director and co-founder of Brainstrust, the Meg Jones tumour charity. She said: “Brain cancer research attracts relatively very little funding compared to other cancers, such as breast, bowel, lung and prostate. This is why raising awareness through this open day is so important.”
It is anticipated that several clinical leading neuro-oncology centres will provide vital tissues and clinical experience while the University will provide medical research programmes, training courses and a state of the art laboratory.
Those already on-board include Hurstwood Park Neurological Centre, Hayward's Heath, Maidstone NHS Hospitals, King's College Hospital, London & Charing Cross Hospital and the Institute of Neurology in London.
Professor Pilkington said that the centre would encourage institutions to collaborate in order for patients to benefit from a research informed environment.
Lisa Egan | alfa
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf
Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.
Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.
Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
18.07.2019 | Health and Medicine
18.07.2019 | Life Sciences
18.07.2019 | Health and Medicine